LOS ANGELES--(BUSINESS WIRE)--As part of its ongoing campaign to lower AIDS drug prices and increase access, AIDS Healthcare Foundation (AHF) today unveiled its latest element in a multifaceted advocacy campaign challenging Merck and Co. Pharmaceuticals over the steep price it charges for its key HIV/AIDS drug, Isentress (raltegravir), the most expensive first-line AIDS therapy in the US today. In a novel approach aimed at educating commuting Merck employees and the general public about the high price the company charges for the drug, AHF placed train station banner advertisements hanging from light poles on the platform of the train station in Whitehouse Station, New Jersey—Merck’s hometown. The colorful vinyl banner ads read, “Merck: Do the Right Thing.” The banners, which began hanging at the station this week, are approximately two feet by three feet in size, also direct viewers to AHF’s website, where visitors can find information about Merck’s AIDS drug pricing and policies regarding Isentress.
